🇺🇸 FDA
Pipeline program

Isoniazid

2015ZX10003001

Approved small_molecule active

Quick answer

Isoniazid for Tuberculosis, Pulmonary is a Approved program (small_molecule) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).

Program details

Company
China SXT Pharmaceuticals
Indication
Tuberculosis, Pulmonary
Phase
Approved
Modality
small_molecule
Status
active

Clinical trials